Metastatic angiosarcomas: Doxorubicin-based regimens, weekly paclitaxel and metastasectomy significantly improve the outcome

Annals of Oncology

Volumn 23, Issue 2, 2012, Pages 517-523

  Penel, N ^a,b   Italiano, A ^c   Ray coquard, I ^d   Chaigneau, L ^e   Delcambre, C ^f   Robin, Y M ^a   Bui, B ^c   Bertucci, F ^g   Isambert, N ^h   Cupissol, D ⁱ   Bompas, E ^j   Bay, J O ^k   Duffaud, F ^l   Guillemet, C ^m   Blay, J Y ^d  

^a CENTRE OSCAR LAMBRET   (France)

^b UNIV LILLE   (France)

^c INSTITUT BERGONIÉ   (France)

^d CENTRE LÉON BÉRARD   (France)

^e UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^f CENTRE FRANÇOIS BACLESSE   (France)

^g INSTITUT PAOLI CALMETTES   (France)

^h CENTRE GEORGES FRANÇOIS LECLERC   (France)

ⁱ CENTRE VAL D AURELLE   (France)

^j CENTRE RENÉ GAUDUCHEAU   (France)

^k CENTRE JEAN PERRIN   (France)

^l TIMONE HOSPITAL   (France)

^m CENTRE HENRI BECQUEREL   (France)

more..

Author keywords

Angiosarcoma; Doxorubicin; Metastases; Prognostic factors; Surgery; Weekly paclitaxel

Indexed keywords

CARBOPLATIN; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; NAVELBINE; PACLITAXEL; SORAFENIB; VINBLASTINE;

ADOLESCENT; ADULT; AGE; AGED; ANGIOSARCOMA; ARTICLE; BONE METASTASIS; CANCER RADIOTHERAPY; CHILD; DRUG EFFICACY; FEMALE; FRANCE; HAZARD RATIO; HUMAN; LIVER METASTASIS; LIVER SURGERY; LUNG METASTASIS; LUNG SURGERY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; METRONOMIC DRUG ADMINISTRATION; ORTHOPEDIC SURGERY; OVERALL SURVIVAL; PALLIATIVE THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX RATIO; TREATMENT OUTCOME; UNIVARIATE ANALYSIS; VASCULAR SURGERY;

EID: 84856346055     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr138     Document Type: Article

References (33)

1. Torosian MH, Friedrich C, Godblod J et al. Soft-tissue sarcoma: initial characteristics and prognostic factors in patients with or without metastatic disease. Sem Surg Oncol 1988; 4: 13-19.
2. Coindre JM, Terrier P, Guillou L et al. Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas. A study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 2001; 91: 1914-1926.
3. Penel N, Grosjean J, Robin YM et al. Frequency of certain established risk factors in soft tissue sarcomas in adult: a prospective descriptive study of 658 cases. Sarcoma 2008; 2008: 459386.
4. Lurkin A, Ducimetière F, Ranchère Vince D et al. Epidemiological evaluation of corcondance between initial diagnosis and central pathology review in a comprehensive and prospective series of patients in the Rhone-Alpes region. BMC Cancer 2010; 10: 150.
5. Rehders A, Hosch SB, Scheunemann P et al. Benefit of surgical treatment of lung metastasis in soft tissue sarcoma. Arch Surg 2007; 142: 70-75.
6. Fury MG, Antonescu CR, Van Zee KJ et al. A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with sugery and chemotherapy. Cancer J 2005; 11: 241-247.
7. Fayette J, Martin E, Piperno-Neumann S et al. Angiosarcomas, a herogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol 2007; 18: 2030-2036.
8. Meis-Kindblom J, Kindblom LG. Angiosarcoma of soft tissue: a study of 80 cases. Am J Surg Pathol 1998; 22: 683-697.
9. Thomas LB, Popper H. Pathology of angiosarcomas of the liver among vinyl chloride-polychloride workers. Ann NY Acad Sci 1975; 246: 268-285.
10. Naka N, Oshawa M, Tomita Y et al. Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 1996; 61: 170-176.
11. Maddox JC, Evans HL. Angiosarcoma of skin and soft tissue. A study of 44 cases. Cancer 1981; 48: 1907-1921.
12. Abraham JA, Hornicek FJ, Kaufman AM et al. Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 2007; 14: 1953-1967.
13. Morgan MB, Swann M, Somach S et al. Cutaneous angiosarcoma: a case series with prognostic correlation. J Am Acad Dermatol 2004; 50: 867-874.
14. Pawlik TM, Paulino AF, Mc Ginn CJ et al. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer 2003; 98: 1716-1726.
15. Mark RJ, Poen JC, Tran LM et al. Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 1996; 77: 2400-2406.
16. Vorburger SA, Xing Y, Hunt KK et al. Angiosarcoma of the breast. Cancer 2005; 104: 2682-2688.
17. Fata F, O'Reilly E, Ilson D et al. Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face. Cancer 1999; 86: 2034-2037.
18. Schlemmer M, Reichardt P, Verweij J et al. Paclitaxel in patients with adanced angiosarcomas of soft tissue: a retrospective study of the EORTC Soft Tissue and Boenne Sarcoma Group. Eur J Cancer 2008; 44: 2433-2436.
19. Skubitz KM, Haddad PA. Paclitaxel and pegylated-liposomal doxorubicin are both active in angiosarcoma. Cancer 2005; 104: 361-366.
20. Penel N, Binh NB, Bay JO et al. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the AngioTax study. J Clin Oncol 2008; 26: 5269-5274.
21. Maurel J, Lopez-Pousa A, de la Penas R et al. Efficacy of sequential high-dose doxorubicin and ifosfamide compared with standrard-dose doxorubicin in patients with advanced soft tissue sarcoma: an open-label randomized phase II study of the Spanish Group for Research on Sarcomas. J Clin Oncol 2009; 27: 1893-1898.
22. Van Glabbeke M, Van Oosterom AT, Van Osterhuis JW et al. Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens-a European Organization of Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 1999; 17: 150-167.
23. Kroep JR, Ouali M, Gelderblom H et al. First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as prognostic factors for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group Study. Ann Oncol 2011; 22: 207-214.
24. Sleijfer S, Seynaeve C, Verweij J. Using single-agent therapy in adult patients with advanced soft tissue sarcoma still be considered standard care. Oncologist 2005; 10: 833-841.
25. Karavasilis V, Seddon BM, Ashley S et al. Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma. Retrospective analysis and identification of prognostic factors in 488 patients. Cancer 2008; 112: 1585-1591.
26. Pivot X, Chevreau C, Cupissol D et al. Phase II trial of paclitaxel-epirubicin in patients with recurrent soft tissue sarcoma. Am J Clin Oncol 2002; 25: 661-664.
27. Verweij J, Lee SM, Ruka W et al. Randomized phase II study of docetaxel versus doxorubicin in first-line and second-line chemotherapy for locally advanced or metastatic soft tissue sarcomas in adults: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. J Clin Oncol 2000; 18: 2081-2086.
28. Köstler WJ, Brodowicz T, Attems Y et al. Docetaxel as rescue medication in anthracyclines-and ifosfamide-resistant locally advanced or metastatic soft tissue sarcoma: results of a phase II trial. Ann Oncol 2001; 12: 1281-1288.
29. Penel N, Italiano A, Isambert N et al. Factors affecting the outcome of patients with metastatic leiomyosarcoma treated with doxorubicin-containing chemotherapy. Ann Oncol 2010; 21: 1361-1365.
30. Casson AG, Putman JB, Natarajan G et al. Five-year survival after pulmonary metastasectomy for adult soft tissue sarcoma. Cancer 1992; 69: 662-668.
31. Gadd MA, Casper ES, Woodruff JM et al. Development and treatment of pulmonary metastases in adult with extremity soft tissue sarcoma. Ann Surg 1993; 218: 705-712.
32. Smith R, Pak Y, Kraybill W, Kane JM III. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol 2009; 35: 356-361.
33. Suzuki M, Iwata T, Ando S et al. Predictors of long-term survival with pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas. J Cardiovasc Surg 2006; 47: 603-608.